Structural Heart Devices Market: Growth, Size, Share, and Trends

Report Code MD 6585
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Structural Heart Devices Market by Product (Heart Valve Devices Transcatheter and Surgical), Occluders, Closure and Delivery Systems, Annuloplasty Rings, Accessories, Procedure (Replacement(TAVR/TAVI), Repair & End-Users - Global Forecast to 2029

Overview

The structural heart devices market is projected to reach USD 25.69 billion by 2029 from USD 16.31 billion in 2024, at a CAGR of 9.5% during the forecast period. The several main factors driving the market of structural heart devices reflect advances in healthcare technology and patient demographics. In this regard, the incidence and prevalence of structural heart diseases, including aortic stenosis and mitral regurgitation, increase with aging populations across the globe. Advancements in minimally invasive procedures using technologies such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) have provided an alternative for open-heart surgery that is safer and more effective. Increasing awareness and an improved rate of early diagnosis of structural heart diseases are proving demanding for sophisticated therapies. Favorable reimbursement policies have also made devices available to patients in many countries. These combined factors create robust growth for the structural heart devices market.

Structural Heart Devices Market

Attractive Opportunities in the Structural Heart Devices Market

Asia Pacific

The growth in the Asia Pacific region is driven by the high rise of the geriatric population and the number of domestic manufacturers in the area.

An increasing prevalence of cardiovascular diseases in the population is due to sedentary lifestyles, smoking habits, and the high consumption of unhealthy fats.

Government reimbursements and awareness programs help diagnose and screen diseases and problems of heart valves.

Emerging economies, such as China India, Brazil, South Korea, and Australia, offer high-growth opportunities for market players. Europe is witnessing the fastest-growing geriatric population.

North America accounted for the largest market share due to the fast adoption of advanced technologies and the high incidence rate of diseases, such as valve repair and replacements.

Global Structural Heart Devices Market Dynamics

DRIVER: Growing geriatric population

This increasing older population is directly proportional to the growing prevalence of diseases, including aortic stenosis, mitral regurgitation, and atrial fibrillation, which are frequently treated interventions using structural heart devices. This demographic trend opens a massive market opportunity for producers of the devices, as healthcare systems must meet the new demand for surgical and minimally invasive solutions oriented toward elderly patients. The economic burden of the already aging populations in the US and Europe is a critical driving factor pushing the demand for structural heart devices, thus offering opportunities for innovation and growth in this field as healthcare providers seek effective medical solutions to age-related cardiovascular pathologies.

According to the US Census Bureau, the growth of the population aged 65 and over was nearly five times that of the total population over the 100 years from 1920 to 2020. The older population reached 55.8 million, or 16.8% of the population of the US in 2021.

RESTRAINT: High cost of devices and limited reimbursement

The high cost of structural heart devices is a major restraint in the market, limiting accessibility and adoption across various regions and patient demographics. These devices, ranging from transcatheter aortic and mitral valve replacement systems and closure devices to other devices, are critical for managing serious structural heart diseases. Their high price affects low- and middle-income countries and the underinsured populations of developed countries across their accessibility. The cost of TAVR systems is more than USD 30,000 for each procedure, which does not bear the costs of other prerequisites, such as imaging before surgery, hospital stays, or care after procedures.

Patients and healthcare systems are left to bear such an enormous financial burden, mainly in underdeveloped areas with scant reimbursement schemes. In addition, the upfront investment needed for hospitals to introduce such technologies as imaging equipment, hybrid operating rooms, and staff training aggravates the strain.

 

OPPORTUNITY: Emergence of tissue-engineered heart valves

The emergence of tissue-engineered heart valves is a crucial opportunity that has arisen recently for structural heart devices primarily because it allows for dealing with the limitations of traditional prosthetic valves. The potential increase in the prevalence of valvular heart disease due to the aging of the population mandates the need for innovative, long-term, durable, and adaptable solutions for the physiological changes of patients. This feature is especially important in younger patients often treated with multiple interventions with conventional valve replacements.

Recent advancements in tissue engineering techniques focus on improving valve designs that incorporate patient-specific cells, thereby allowing for higher biocompatibility and reduced risks of immune rejection. For instance, using autologous stem cells or decellularized matrices makes it possible to fabricate living implants that could be integrated into the body more effectively than traditional materials. TEHVs have been demonstrated in preclinical models to show good performance and remodeling capacity and should be brought to the clinic. Additional support to the market opportunity of TEHVs is given by increasing public and private investment in research in regenerative medicine and tissue engineering. Tissue-engineered solutions have become a preferable alternative as healthcare providers look toward better patient outcomes with long-term cost savings on valve replacement surgeries. Moreover, as the regulatory agencies realize the significance of such innovations, expedited approval and ease of entry into the market are potential gates.

CHALLENGES: Regulatory and approval challenges

The regulatory environment affects the market of structural heart devices due to enormous challenges that influence speed and efficiency in the entry of new products into the market. The principal challenge manufacturers face in this industry is diverse and complex regulations that differ from country to country. For instance, in the US, the Food and Drug Administration (FDA) is very strict in controlling the regulation of approval of medical devices. The processes involved include careful preclinical testing, clinical trials, and post-market surveillance. Such processes may be lengthy and expensive, causing delays in product launch and high development costs in most cases.

The increased scrutiny of medical devices from the new regulations under the MDR will introduce the need to ensure that such devices are sufficiently and rigorously clinically evaluated as well as post-market monitored, thereby leading to a longer time to approval for manufacturers seeking or wishing to expand within the European markets and increased costs. Hence, although the market for structural heart devices is likely to grow even higher because cardiovascular diseases are increasingly prevalent and the population grows old, such regulatory obstacles remain a significant challenge that market stakeholders must skillfully navigate. Many of these problems could be addressed by streamlined processes and more transparent guidelines, thereby hastening access to new treatments for patients.

Global Structural Heart Devices Market Ecosystem Analysis

The structural heart devices market ecosystem involves various stakeholders and technologies. Peripheral vascular devices represent a complex ecosystem where manufacturers such as Abbott (US) and Medtronic (UK) coexist with healthcare providers, including hospitals, clinics, and vascular surgeons, as well as regulatory bodies such as the Food Drug Administration (FDA) and the European Medicines Agency (EMA). Central in this market are the technologies of angioplasty balloons, stents, catheters, and drug-eluting devices for various conditions, including PAD and venous insufficiency. R&D is performed through collaborative networking and interaction by clinicians, researchers, and industry players, and regulatory approval addresses the problems of safety and efficacy in their use in clinics.

Structural Heart Devices Market
 

The heart valve devices segment witnessed the highest growth during the forecast period.

Based on products, the structural heart devices are segmented into – heart valve devices, occluders, closure systems, and delivery systems, annuloplasty rings, and accessories. The heart valve device segment is further divided into transcatheter heart valves and surgical heart valves. The transcatheter heart valve segment is witnessed to have the highest growth in the heart valve segment.

The Transcatheter Heart Valve (THV) segment would be the most influential within the structural heart devices market, mainly due to a few imperative factors. The incidence of valvular heart disease is witnessing soaring growth, especially among the geriatric population. As the global population is aging, conditions such as aortic stenosis are becoming more common, thus creating an urgent need for such treatment devices to be available. It is such a fact that cardiovascular diseases cause deaths to about 17.9 million people annually, which makes this minimally invasive procedure all the more relevant.

Technological advancements also play a critical role in the success factors driving the growth of the THV market. Third-generation THVs introduce advanced procedural outcomes and expand the treatable population. The newer devices have enhanced design features that foster easier implantation and superior hemodynamic performance, furthering its attractiveness to healthcare providers. For instance, through the progress made in valve delivery systems, procedures are less invasive and, therefore, have shorter recovery times and lower hospital stays - more attractive to patients and surgeons.

By procedure, the replacement procedures segment is expected to have the highest growth during the forecast period.

Replacement procedures generally have a higher share in structural heart devices because of versatility, effectiveness, and longevity. Aortic stenosis and mitral regurgitation require replacement procedures, which are viable when repair fails. Replacement procedures such as TAVR and TMVR are less invasive compared to traditional open-heart surgeries. They are thus preferable for patients who are elderly or high-risk surgical candidates.

Advances in transcatheter technologies have also spurred this trend by shortening recovery times and complications, thus opening the procedures to a larger patient population. In contrast, repair procedures are more complex and require special surgical expertise and precise patient selection, thus limiting their widespread use. In addition, regulatory approvals, along with significant clinical data on the safety and efficacy of replacement devices, increase their adoption by healthcare providers.

North America accounted for the largest share of the structural heart devices market in 2023.

North America is one of the leading markets for structural heart devices due to its well-developed healthcare infrastructure, better hospitals, and special clinics that can quickly adopt and integrate new vascular technologies and treatments. Leading medical device manufacturers from the US, such as Edwards Lifesciences Corporation, Medtronic, Abbott, and Boston Scientific, ensure constant market growth owing to their continuous innovation and easy access to the latest and most significant devices.

North America held the largest regional share in terms of structural heart devices. This is attributed to a favorable environment regarding healthcare, which promotes the use of advanced medical technologies. The widespread incidence of cardiovascular diseases, particularly valvular heart diseases, has also encouraged the growth of the market in this region. According to the South Carolina Internal Medicine LLC, almost 60 million people in the US suffer from structural heart defects in 2024, which drives the demand for structural heart devices.

Well-established healthcare infrastructures in North America are also driving the growth in this region. Specialized heart centers, highly trained cardiologists, and advanced surgical facilities have achieved timely diagnosis and effective treatments for cardiac diseases. In addition, good reimbursement policies in the US and Canada have made these products accessible to more patients, encouraging patients and healthcare providers to choose minimally invasive procedures such as transcatheter heart valve replacements.

HIGHEST CAGR MARKET IN 2024-2030
US FASTEST GROWING MARKET IN THE REGION
Structural Heart Devices Market

Recent Developments of Structural Heart Devices Market

  • In March 2024, Medtronic (UK) received product approval for its EvolutFX+ transcatheter aortic valve replacement systems for the treatment of symptomatic severe aortic stenosis.
  • In August 2024, Edwards Lifesciences Corporation acquired JenaValve Technology (UK), a pioneer in the transcatheter treatment of aortic regurgitation, thereby strengthening its product portfolio.
  • In January 2023, Abbott (US) received product approval for Navitor, the only self-expanding TAVI system.
  • In June 2023, Teleflex (US) received product approval for Wattson Temporary pacing guidewire which is used for TAVR and balloon aortic valvuloplasty.

Key Market Players

Want to explore hidden markets that can drive new revenue in Structural Heart Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million)
Segments covered By Product, Procedure, End Users and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Key Questions Addressed by the Report

What is the expected addressable market value of the structural heart devices market over 5 years?
The structural heart devices market is projected to reach USD 25.69 billion by 2029, at a CAGR of 9.5% during the forecast period.
Which segment is expected to garner the highest traction within the structural heart devices market?
The heart valve segment is expected to witness the highest growth in the structural heart devices market.
Which segment is expected to garner the highest growth rate traction within the heart valve devices?
The transcatheter heart valve segment is expected to register the highest growth rate during the forecast period.
What strategies are top market players adopting to penetrate emerging regions?
The major players in the market adopt partnerships, agreements, product launches, and product approvals as important growth tactics.
What are the major factors expected to limit the growth of the structural heart devices market?
Stringent regulatory scenarios and reduced product approvals for structural heart devices are major limiting factors for market growth.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Structural Heart Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
47
PREMIUM INSIGHTS
51
MARKET OVERVIEW
54
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing geriatric population
    - Increasing preference for minimally invasive surgeries
    - Rising awareness about structural heart diseases
    RESTRAINTS
    - High cost of devices and limited reimbursement
    OPPORTUNITIES
    - Emergence of tissue-engineered heart valves
    - Expanding healthcare facilities in emerging economies
    CHALLENGES
    - Regulatory and approval challenges
    - Intense competition among market players
    - Lack of skilled professionals
  • 5.3 INDUSTRY TRENDS
    MINIMALLY INVASIVE PROCEDURES
    TECHNOLOGICAL ADVANCEMENTS IN DEVICE DESIGN
    AI AND MACHINE LEARNING INTEGRATION
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE, BY KEY PLAYER
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Transcatheter aortic valve replacement
    - Transcatheter mitral aortic valve replacement
    COMPLEMENTARY TECHNOLOGIES
    - 3D printing
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    HS CODES
    EXPORT DATA
    IMPORT DATA
  • 5.13 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.14 CASE STUDY ANALYSIS
    SAPIEN 3 TRANSCATHETER HEART VALVE FOR PRECISION PLACEMENT
    MITRACLIP TRANSCATHETER EDGE-TO-EDGE REPAIR TO REDUCE HOSPITALIZATION
    WATCHMAN FLX DEVICE FOR LEFT ATRIAL APPENDAGE
  • 5.15 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.16 PORTER’S FIVE FORCE ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS
    BUYING CRITERIA
  • 5.18 REIMBURSEMENT ANALYSIS
  • 5.19 UNMET NEEDS AND END-USER EXPECTATIONS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.20 IMPACT OF AI/GEN AI ON STRUCTURAL HEART DEVICES MARKET
    INTRODUCTION
    KEY COMPANIES IMPLEMENTING AI
    MARKET POTENTIAL OF AI IN STRUCTURAL HEART DEVICES MARKET
STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE
91
  • 6.1 INTRODUCTION
  • 6.2 REPLACEMENT PROCEDURES
    TAVR/TAVI REPLACEMENT PROCEDURES
    - Quicker recuperation and shorter hospital stays to promote growth
    SAVR PROCEDURES
    - Wide adoption for treating valvular heart diseases to sustain growth
  • 6.3 REPAIR PROCEDURES
    CLOSURE PROCEDURES
    - Increasing prevalence of structural heart defects to boost market
    ANNULOPLASTY
    - Growing focus on safety and efficacy to drive market
    VALVULOPLASTY
    - Increasing cases of aortic stenosis and valvular regurgitation to fuel market
    TMVR PROCEDURES
    - Growing preference over valve replacement to promote growth
    TEER PROCEDURES
    - Global prevalence of mitral regurgitation to expedite growth
STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
105
  • 7.1 INTRODUCTION
  • 7.2 HEART VALVE DEVICES
    TRANSCATHETER HEART VALVES
    - Transcatheter mitral valve replacement
    - Transcatheter aortic valve replacement
    SURGICAL VALVES
    - Mechanical valves
    - Biological valves
  • 7.3 OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS
  • 7.4 ANNULOPLASTY RINGS
    HIGH PREVALENCE OF MITRAL AND TRICUSPID VALVE REGURGITATION DISEASES TO PROMOTE GROWTH
  • 7.5 ACCESSORIES
    CATHETERS
    - Growing preference for minimally invasive procedures to fuel market
    GUIDEWIRES
    - Need for precise navigation and placement of medical devices to augment growth
    SHEATHS
    - Need for minimizing vascular trauma to promote growth
    OTHER ACCESSORIES
STRUCTURAL HEART DEVICES MARKET, BY END USER
128
  • 8.1 INTRODUCTION
    HOSPITALS
    - Ability to handle large volume of patients to boost market
    AMBULATORY SURGICAL CENTRES
    - Faster procedure time and lower infection rates to drive market
    OTHER END USERS
STRUCTURAL HEART DEVICES MARKET, BY REGION
133
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Favorable reimbursement scenario to augment growth
    CANADA
    - Rising prevalence of target diseases to drive market
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increase in geriatric and obese population to stimulate growth
    UK
    - Increasing incidence of peripheral vascular diseases to support growth
    FRANCE
    - Favorable government initiatives to drive market
    ITALY
    - Increasing health expenditure and rising diabetes prevalence to boost market
    SPAIN
    - Growing geriatric population to propel market
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Increasing healthcare expenditure to boost market
    CHINA
    - Growing target patient population to drive market
    INDIA
    - Increasing prevalence of diabetes to expedite growth
    AUSTRALIA
    - Growing hospitalizations due to coronary artery diseases to fuel market
    SOUTH KOREA
    - Increasing prevalence of hypertension to support growth
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Rising healthcare expenditure to aid growth
    MEXICO
    - Increasing prevalence of cardiovascular diseases to spur growth
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Rising cases of hypertension and associated cardiovascular diseases to drive market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
229
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE ANALYSIS, 2019–2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Product footprint
    - Procedure footprint
    - End-user footprint
    - Region footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    RESPONSIVE COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 COMPANY VALUATION AND FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
COMPANY PROFILES
246
  • 11.1 KEY PLAYERS
    EDWARDS LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    TELEFLEX
    - Business overview
    - Products offered
    - Recent developments
    INTEGER HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    LEPU MEDICAL TECHNOLOGY CO., LTD.
    - Business overview
    - Products offered
    - Recent developments
    TTK HEALTHCARE
    - Business overview
    - Products offered
    ARTIVION, INC.
    - Business overview
    - Products offered
    VENUS MEDTECH (HANGZHOU) INC.
    - Business overview
    - Products offered
    - Recent developments
    LIFETECH SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    COOK
    - Business overview
    - Products offered
    - Recent developments
    CORDIS
    - Business overview
    - Products offered
    - Recent developments
    SMT
    - Business overview
    - Products offered
    - Recent developments
    MERIL LIFE SCIENCES PVT. LTD.
    - Business overview
    - Products offered
    W. L. GORE & ASSOCIATES, INC.
    - Business overview
    - Products offered
  • 11.2 OTHER PLAYERS
    FOLDAX
    MICRO INTERVENTIONAL DEVICES, INCORPORATED
    CARDIAC DIMENSIONS
    BIOTRONIK
    HIGHLIFE MEDICAL
    MITRALIGN
    BRAILE BIOMEDICA
    JENAVALVE
    CORCYM
    XELTIS
    INNOVHEART SRL
APPENDIX
298
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2020–2023
  • TABLE 2 STRUCTURAL HEART DEVICES MARKET: RESEARCH ASSUMPTIONS
  • TABLE 3 STRUCTURAL HEART DEVICES MARKET: RISK ASSESSMENT
  • TABLE 4 GERIATRIC POPULATION, BY REGION, 2030
  • TABLE 5 NATIONAL AVERAGE REIMBURSEMENT RATES FOR NORTH AMERICA AND EUROPE, 2024–2025
  • TABLE 6 STRUCTURAL HEART DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 STRUCTURAL HEART DEVICES MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2023
  • TABLE 8 HS CODES FOR STRUCTURAL HEART DEVICES MARKET
  • TABLE 9 EXPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023
  • TABLE 10 IMPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023
  • TABLE 11 STRUCTURAL HEART DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 STRUCTURAL HEART DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
  • TABLE 19 KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
  • TABLE 20 CPT CODES FOR STRUCTURAL HEART DEVICES MARKET
  • TABLE 21 STRUCTURAL HEART DEVICES MARKET: UNMET NEEDS
  • TABLE 22 STRUCTURAL HEART DEVICES MARKET: END-USER EXPECTATIONS
  • TABLE 23 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 24 STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 25 STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 STRUCTURAL HEART DEVICES MARKET FOR TAVR/TAVI PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 STRUCTURAL HEART DEVICES MARKET FOR SAVR PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 28 STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 STRUCTURAL HEART DEVICES MARKET FOR CLOSURE PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 STRUCTURAL HEART DEVICES MARKET FOR VALVULOPLASTY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 STRUCTURAL HEART DEVICES MARKET FOR TMVR PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 34 STRUCTURAL HEART DEVICES MARKET FOR TEER PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 36 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 37 STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 38 STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 42 STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 STRUCTURAL HEART DEVICES MARKET FOR MECHANICAL VALVES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 STRUCTURAL HEART DEVICES MARKET FOR BIOLOGICAL VALVES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 STRUCTURAL HEART DEVICES MARKET FOR OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY RINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 48 STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 STRUCTURAL HEART DEVICES MARKET FOR CATHETERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 STRUCTURAL HEART DEVICES MARKET FOR GUIDEWIRES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 STRUCTURAL HEART DEVICES MARKET FOR SHEATHS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 STRUCTURAL HEART DEVICES MARKET FOR OTHER ACCESSORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 54 STRUCTURAL HEART DEVICES MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 STRUCTURAL HEART DEVICES MARKET FOR AMBULATORY SURGICAL CENTRES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 STRUCTURAL HEART DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: HEART VALVE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 68 US: KEY MACROECONOMIC INDICATORS
  • TABLE 69 US: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 70 US: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 71 US: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 72 US: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 73 US: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 74 US: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 75 US: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 76 US: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 77 US: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 78 CANADA: KEY MACROECONOMIC INDICATORS
  • TABLE 79 CANADA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 80 CANADA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 81 CANADA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 CANADA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 CANADA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 CANADA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 85 CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 CANADA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 88 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 90 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 97 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 98 GERMANY: KEY MACROECONOMIC INDICATORS
  • TABLE 99 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022– 2029 (USD MILLION)
  • TABLE 100 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 GERMANY: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 105 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 106 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 108 UK: KEY MACROECONOMIC INDICATORS
  • TABLE 109 UK: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 110 UK: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 UK: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 UK: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 UK: STRUCTURAL HEART DEVICES FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 UK: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 115 UK: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 116 UK: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 UK: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 118 FRANCE: KEY MACROECONOMIC INDICATORS
  • TABLE 119 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 120 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 FRANCE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 125 FRANCE: STRUCTURAL HEART DEVICES FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 127 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 128 ITALY: KEY MACROECONOMIC INDICATORS
  • TABLE 129 ITALY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 130 ITALY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 ITALY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 ITALY: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 ITALY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 ITALY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 135 ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 ITALY: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 138 SPAIN: KEY MACROECONOMIC INDICATORS
  • TABLE 139 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 140 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 SPAIN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 145 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2030 (MILLION)
  • TABLE 149 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,2022–2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 155 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 156 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 157 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 168 JAPAN: KEY MACROECONOMIC INDICATORS
  • TABLE 169 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 170 JAPAN: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 171 JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 175 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 176 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 178 CHINA: KEY MACROECONOMIC INDICATORS
  • TABLE 179 CHINA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 180 CHINA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 CHINA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 CHINA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 185 CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 186 CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 CHINA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 188 INDIA: KEY MACROECONOMIC INDICATORS
  • TABLE 189 INDIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 190 INDIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 INDIA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 192 INDIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 193 INDIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 INDIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 195 INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 196 INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 INDIA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: KEY MACROECONOMIC INDICATORS
  • TABLE 199 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 200 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 AUSTRALIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 AUSTRALIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 205 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 208 SOUTH KOREA: KEY MACROECONOMIC INDICATORS
  • TABLE 209 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 210 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 215 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 216 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 218 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 219 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 224 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 225 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 226 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 227 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 229 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 234 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 235 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 237 BRAZIL: KEY MACROECONOMIC INDICATORS
  • TABLE 238 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 239 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 BRAZIL: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 244 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 245 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 247 MEXICO: KEY MACROECONOMIC INDICATORS
  • TABLE 248 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 249 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 MEXICO: STRUCTURAL HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022–2029 (USD MILLION)
  • TABLE 251 MEXICO: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 254 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 255 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 MEXICO: STRUCTURAL HEART DEVICES, MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 257 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 258 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 263 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 266 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 267 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 268 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST & AFRICA: HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022–2029 (USD MILLION)
  • TABLE 270 MIDDLE EAST & AFRICA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 273 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 274 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 276 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 277 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY ACCESSORIES, 2022–2029 (USD MILLION)
  • TABLE 281 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 282 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 283 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 284 GCC COUNTRIES: STRUCTURAL HEART DEVICES, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 293 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 294 STRUCTURAL HEART DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 295 STRUCTURAL HEART DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 296 STRUCTURAL HEART DEVICES MARKET: PROCEDURE FOOTPRINT
  • TABLE 297 STRUCTURAL HEART DEVICES MARKET: END-USER FOOTPRINT
  • TABLE 298 STRUCTURAL HEART DEVICES MARKET: REGION FOOTPRINT
  • TABLE 299 STRUCTURAL HEART DEVICES MARKET: KEY STARTUPS/SMES
  • TABLE 300 STRUCTURAL HEART DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 301 STRUCTURAL HEART DEVICES MARKET: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 302 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 303 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 304 EDWARDS LIFESCIENCES CORPORATION: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 305 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 306 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 307 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 308 MEDTRONIC: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 309 ABBOTT: COMPANY OVERVIEW
  • TABLE 310 ABBOTT: PRODUCTS OFFERED
  • TABLE 311 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 312 ABBOTT: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 313 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 314 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 315 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 316 TELEFLEX: COMPANY OVERVIEW
  • TABLE 317 TELEFLEX: PRODUCTS OFFERED
  • TABLE 318 TELEFLEX: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 319 TELEFLEX: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 320 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 321 INTEGER HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 322 INTEGER HOLDINGS CORPORATION: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 323 INTEGER HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 324 LEPU MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 325 LEPU MEDICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 326 LEPU MEDICAL CO, .LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 327 TTK HEALTHCARE: COMPANY OVERVIEW
  • TABLE 328 TTK HEALTHCARE: PRODUCTS OFFERED
  • TABLE 329 ARTIVION, INC.: COMPANY OVERVIEW
  • TABLE 330 ARTIVION, INC.: PRODUCTS OFFERED
  • TABLE 331 VENUS MEDTECH (HANGZHOU) INC.: COMPANY OVERVIEW
  • TABLE 332 VENUS MEDTECH (HANGZHOU) INC.: PRODUCTS OFFERED
  • TABLE 333 VENUS MEDTECH (HANGZHOU) INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 334 LIFETECH SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 335 LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 336 COOK: COMPANY OVERVIEW
  • TABLE 337 COOK: PRODUCTS OFFERED
  • TABLE 338 COOK: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 339 CORDIS: COMPANY OVERVIEW
  • TABLE 340 CORDIS: PRODUCTS OFFERED
  • TABLE 341 CORDIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 342 SMT: COMPANY OVERVIEW
  • TABLE 343 SMT: PRODUCTS OFFERED
  • TABLE 344 SMT: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024
  • TABLE 345 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
  • TABLE 346 MERIL LIFESCIENCES PVT. LTD.: PRODUCTS OFFERED
  • TABLE 347 W.L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
  • TABLE 348 W.L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
  • TABLE 349 FOLDAX: COMPANY OVERVIEW
  • TABLE 350 MICRO INTERVENTIONAL DEVICES, INCORPORATED: COMPANY OVERVIEW
  • TABLE 351 CARDIAC DIMENSIONS: COMPANY OVERVIEW
  • TABLE 352 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 353 HIGHLIFE MEDICAL: COMPANY OVERVIEW
  • TABLE 354 MITRALIGN: COMPANY OVERVIEW
  • TABLE 355 BRAILE BIOMEDICA: COMPANY OVERVIEW
  • TABLE 356 JENAVALVE: COMPANY OVERVIEW
  • TABLE 357 CORCYM: COMPANY OVERVIEW
  • TABLE 358 XELTIS: COMPANY OVERVIEW
  • TABLE 359 INNOVHEART SRL: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE COVERED
  • FIGURE 2 STRUCTURAL HEART DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 6 STRUCTURAL HEART DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 7 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
  • FIGURE 8 STRUCTURAL HEART DEVICES MARKET: CAGR PROJECTIONS, 2024–2029
  • FIGURE 9 DATA TRIANGULATION
  • FIGURE 10 STRUCTURAL HEART DEVICES, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 STRUCTURAL HEART DEVICES MARKET FOR HEART VALVES, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 STRUCTURAL HEART DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHIC SNAPSHOT OF GLOBAL STRUCTURAL HEART DEVICES MARKET
  • FIGURE 15 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • FIGURE 16 US AND HEART VALVE DEVICES LED NORTH AMERICAN MARKET IN 2023
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 STRUCTURAL HEART DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 INDUSTRY TRENDS IN STRUCTURAL HEART DEVICES MARKET
  • FIGURE 20 STRUCTURAL HEART DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
  • FIGURE 21 AVERAGE SELLING PRICE TREND OF TRANSCATHETER HEART VALVES, BY REGION, 2021–2023 (USD)
  • FIGURE 22 AVERAGE SELLING PRICE TREND OF SURGICAL HEART VALVES, BY REGION, 2021–2023 (USD MILLION)
  • FIGURE 23 AVERAGE SELLING PRICE OF BIOLOGICAL VALVES, BY KEY PLAYER (2023)
  • FIGURE 24 STRUCTURAL HEART DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 STRUCTURAL HEART DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 STRUCTURAL HEART DEVICES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 27 STRUCTURAL HEART DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2018–2023
  • FIGURE 28 STRUCTURAL HEART DEVICES MARKET: PATENT ANALYSIS, JANUARY 2014–NOVEMBER 2024
  • FIGURE 29 STRUCTURAL HEART DEVICES MARKET: PORTER’S FIVE FORCE ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL HEART DEVICES, BY PRODUCT
  • FIGURE 31 KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT
  • FIGURE 32 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET SNAPSHOT
  • FIGURE 33 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET SNAPSHOT
  • FIGURE 34 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET
  • FIGURE 35 REVENUE ANALYSIS FOR KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET, 2019–2023
  • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET (2023)
  • FIGURE 37 STRUCTURAL HEART DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 38 STRUCTURAL HEART DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 39 STRUCTURAL HEART DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 40 STRUCTURAL HEART DEVICES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 44 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 46 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 47 TELEFLEX: COMPANY SNAPSHOT (2023)
  • FIGURE 48 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 LEPU MEDICAL CO., LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 TTK HEALTHCARE: COMPANY SNAPSHOT (2023)
  • FIGURE 51 ARTIVION, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 VENUS MEDTECH (HANGZHOU) INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)

The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

The following is a breakdown of the primary respondents:

Structural Heart Devices Market

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue.

As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the Structural heart devices market includes the following details.

The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

Structural Heart Devices Market

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

Market Definition

Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

Stakeholders

  • Medical Device Manufacturers
  • Cardiologists
  • Interventional Cardiologist
  • Healthcare institutions (hospitals and outpatient clinics)
  • Distributors and suppliers
  • Research institutes
  • Health insurance payers
  • Market research and consulting firms

Report Objectives

  • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
  • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
  • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

Previous Versions of this Report

Structural Heart Devices Market by Product (Heart Valve Devices Transcatheter and Surgical), Occluders, Closure and Delivery Systems, Annuloplasty Rings, Accessories, Procedure (Replacement(TAVR/TAVI), Repair & End-Users - Global Forecast to 2029

Report Code MD 6585
Published in Sep, 2018, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Structural Heart Devices Market

DMCA.com Protection Status